SCHEMBL23288610

SCHEMBL23288610

COC(=O)C1CCB(C#N)CC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TP53 P04637 1/20 0.41
▸ GAA P10253 1/20 0.39
▸ SMN1; SMN2 Q16637 2/20 0.39
▸ ALDH1A1 P00352 2/20 0.36
▸ CHRNB2 P17787 2/20 0.36
▸ CHRNA4 P43681 2/20 0.36
▸ CHRNB4 P30926 1/20 0.36
▸ CHRNA3 P32297 1/20 0.36
▸ CHRNA7 P36544 1/20 0.36
▸ POLB P06746 2/20 0.36
▸ KCNMA1 Q12791 1/20 0.34
▸ PPM1B O75688 1/20 0.34
▸ PTPN1 P18031 1/20 0.34
▸ PPP1CC P36873 1/20 0.34
▸ TSHR P16473 1/20 0.34
▸ LMNA P02545 1/20 0.34
▸ CYP1A2 P05177 1/20 0.34
▸ CYP2D6 P10635 1/20 0.34
▸ CYP2C9 P11712 1/20 0.34
▸ CYP2C19 P33261 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acetonitrile SCHEMBL28144367 0.78 SMN1; SMN2 (0.55) TP53GAASMN1; SMN2ALDH1A1CHRNB2
SCHEMBL24890582 0.74 — —
SCHEMBL2948892 0.73 TP53 (0.56) TP53GAASMN1; SMN2ALDH1A1CHRNB2
SCHEMBL74396 0.73 TP53 (0.56) TP53GAASMN1; SMN2ALDH1A1CHRNB2
SCHEMBL244740 0.73 — —
SCHEMBL2200767 0.73 TP53 (0.56) TP53GAASMN1; SMN2ALDH1A1CHRNB2
SCHEMBL23486494 0.73 DPP4 (0.37) —
SCHEMBL23486736 0.73 ALDH1A1 (0.31) ALDH1A1
SCHEMBL22280725 0.72 TP53 (0.43) TP53GAASMN1; SMN2ALDH1A1CHRNB2
SCHEMBL442253 0.72 TP53 (0.43) TP53GAASMN1; SMN2ALDH1A1CHRNB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021078120-A1 COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF PARASITIC DISEASES NOVARTIS AG (CH) 2021-04-29 — — WO disclosed
Send feedback